Recombinant Human CD40/TNFRSF5 Protein, C-His
Overview
Catalog No.
HB782011
Form
Lyophilized
Storage buffer
Lyophilized from a solution in PBS pH 7.4, 1 mM EDTA, 4% Trehalose, 1% Mannitol.
Purity
>90% as determined by SDS-PAGE.
Applications
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Endotoxin level
Please contact with the lab for this information.
Expression system
Mammalian Cells
Accession
P25942
Protein length
Met1-Arg193
Nature
Recombinant
Predicted molecular weight
22.32 kDa
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Reconstitution
Reconstitute in sterile water for a stock solution.A copy of datasheet will be provided with the products, please refer to it for details.
Alternative name
Tumor necrosis factor receptor superfamily member 5, B-cell surface antigen CD40, Bp50, CD40L receptor, TNFRSF5, CDw40, CD40
Species
Homo sapiens (Human)
Shipping
In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Note
For research use only.
Images
SDS-PAGE
SDS-PAGE for Recombinant Human CD40/TNFRSF5 Protein, C-His
Bioactivity
Detects Tecaginlimab in indirect ELISAs.
Bioactivity
Detects Human CD40/TNFRSF5 Antibody (SAA1387) in indirect ELISAs.
Bioactivity
Detects Human CD40/TNFRSF5 Antibody in indirect ELISAs.
Bioactivity
Detects Bleselumab in indirect ELISAs.
Bioactivity
Detects Selicrelumab in indirect ELISAs.
Bioactivity
Detects Mitazalimab in indirect ELISAs.
Bioactivity
Detects Dacetuzumab in indirect ELISAs.
Bioactivity
Detects Sotigalimab in indirect ELISAs.
Bioactivity
Detects Ravagalimab in indirect ELISAs.
Bioactivity
Detects Lucatumumab in indirect ELISAs.
Bioactivity
Detected by Research Grade Teneliximab in indirect ELISA.
Bioactivity
Detected by Research Grade Anti-Human CD40/TNFRSF5 (KPL-404) (Cat No.: HB782226) in indirect ELISA.